Y200-6697 Screening compound: N-(1H-1,3-benzodiazol-2-yl)-4-bromobenzamide

Y200-6697 Screening compound: N-(1H-1,3-benzodiazol-2-yl)-4-bromobenzamide
Y200-6697 Screening compound: N-(1H-1,3-benzodiazol-2-yl)-4-bromobenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-6697
N-(1H-1,3-benzodiazol-2-yl)-4-bromobenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-6697

Molecular Formula

C14H10BrN3O (C14 H10 BrN3 O)

Compound Name

N-(1H-1,3-benzodiazol-2-yl)-4-bromobenzamide

IUPAC name

N-(1H-13-benzodiazol-2-yl)-4-bromobenzamide

SMILES

O=C(c(cc1)ccc1Br)Nc1nc(cccc2)c2[nH]1

InChI

InChI=1S/C14H10BrN3O/c15-10-7-5-9(6-8-10)13(19)18-14-16-11-3-1-2-4-12(11)17-14/h1-8H,(H2,16,17,18,19)

InChI Key

UYUOVCOCEWUUHB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00613833

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

316.16

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

3.185

Distribution Coefficient, logD

3.175

Water Solubility, LogSw

-3.55

Polar Surface Area

43.755

Acid Dissociation Constant (pKa)

9.06

Base Dissociation Constant (pKb)

3.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

0.00

Y200-6697 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

Antiviral Annotated Library (21441 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

Human Receptors Annotated Library (5376 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • Epigenetic
Targets:
  • Proteases
  • Kinases

References: we are preparing a list of scientific research reports with Y200-6697 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-6697?
Check Price and Availability of Y200-6697, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-6697 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-6697
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-6697
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-6697 available by request